Xcout Intel
StratifAI competitors & alternatives
The 12 closest competitors and alternatives to StratifAI among artificial intelligence companies — ranked by similarity to what StratifAI actually does, not by market-cap band.
Subscribe to see StratifAI’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About StratifAI
StratifAI is a precision oncology company developing the next generation of biomarkers to advance cancer diagnostics using its Polaris discovery platform. The company is headquartered in Berlin, Germany.
StratifAI at a glance
StratifAI is an artificial intelligence company headquartered in Germany. Its most recent funding round, Pre-Seed, closed in September 2025. Xcout tracks 1 named person at StratifAI, including Omar El Nahhas (CEO and co-founder).
StratifAI leadership
- Omar El NahhasCEO and co-founder
StratifAI funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | Undisclosed | 7 named | |
| Pre-Seed | Undisclosed | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 StratifAI competitors
Ranked by semantic similarity — how close each company is to StratifAI by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech, AI/ML
Pangea Biomed, founded in 2018 and headquartered in Tel Aviv, Israel, is a biotechnology company focused on cancer. Its mission is to democratize precision oncology, bringing deep tumor intelligence to drug development and treatment nomination.
AI/ML
Ataraxis AI is an artificial intelligence company headquartered in New York that links AI model predictions to real patient outcomes across oncology.
AI-driven Drug Discovery
Cellyrix Therapeutics is a biotechnology company founded in 2024 and headquartered in Rehovot, Israel. The company leverages single-cell RNA sequencing and artificial intelligence to develop cancer treatments by addressing tumor heterogeneity and cell-state modulation.
AI/ML
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
Healthcare AI
PreciseDx, Inc. provides an AI-powered platform called OncoIntelligence and its specific product, PreciseBreast, to analyze tissue samples and determine breast cancer recurrence risk. The company serves oncologists, surgeons, pathologists, payors, and patients by offering objective risk stratification and phenotype insights within hours.
AI/ML (Drug Discovery)
ONCOCROSS Co., Ltd. is a public company headquartered in Seoul, South Korea. The company specializes in AI-driven drug discovery, focusing on making drugs work effectively.
AI Diagnostics, Drug Discovery
Headquartered in London, United Kingdom, Case 45 is an AI-based biotechnology business focused on tumor-infiltrating lymphocytes and cancer assessment.
AI/ML
Owkin builds artificial intelligence solutions to automate biopharmaceutical research and development and support clinical research. Its core product, K Pro, is an AI agent that analyzes multimodal patient data to generate insights, inform decision-making, and assist biopharma and healthcare professionals.
AI, Medical Technology
Quibim provides an AI-powered, cloud-based platform and software-as-a-medical-device products that extract radiomics and imaging biomarkers from medical scans. The company serves healthcare providers and life sciences organizations by offering automated image analysis tools for organs such as the prostate, brain, liver, breast, and lungs to improve diagnostics, clinical research, and drug development.
AI/ML
Synagen AI is a bootstrapped healthcare technology company headquartered in Dresden, Germany, focused on developing pioneering AI-driven agents for oncology and medical advancements.
Similar artificial intelligence company
deepc is a digital medicine pioneer headquartered in Munich, Germany, that provides a clinical AI infrastructure platform allowing health systems to easily deploy and govern AI workflows.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of StratifAI and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for StratifAIand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →